BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21122409)

  • 1. [Expression and significance of N-cadherin and β-catenin protein in osteosarcoma].
    Yang JZ; Zhang XH; Liu JR; Ding Y; Gao F; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):586-9. PubMed ID: 21122409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-catenin is a valuable marker for differential diagnosis of osteoblastoma and osteosarcoma.
    Wan Y; Zhao W; Jiang Y; Liu D; Meng G; Cai Y
    Hum Pathol; 2014 Jul; 45(7):1459-65. PubMed ID: 24746516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High grade osteosarcoma of the extremities metastatic to the lung: long-term results in 323 patients treated combining surgery and chemotherapy, 1985-2005.
    Briccoli A; Rocca M; Salone M; Guzzardella GA; Balladelli A; Bacci G
    Surg Oncol; 2010 Dec; 19(4):193-9. PubMed ID: 19515554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD138 (syndecan-1) expression in bone-forming tumors.
    Nunez AL; Siegal GP; Reddy VV; Wei S
    Am J Clin Pathol; 2012 Mar; 137(3):423-8. PubMed ID: 22338054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of osteopontin and vascular endothelial growth factor in benign and malignant bone tumors.
    Sulzbacher I; Birner P; Trieb K; Lang S; Chott A
    Virchows Arch; 2002 Oct; 441(4):345-9. PubMed ID: 12404059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical profile of ephrin A4 expression in human osteosarcoma.
    Abdou AG; Abd El-Wahed MM; Asaad NY; Samaka RM; Abdallaha R
    APMIS; 2009 Apr; 117(4):277-85. PubMed ID: 19338516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndecan-4 and fibronectin in osteosarcoma.
    Na KY; Bacchini P; Bertoni F; Kim YW; Park YK
    Pathology; 2012 Jun; 44(4):325-30. PubMed ID: 22531343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene profiling of MAPK pathway in human osteosarcoma].
    Li GD; Cai ZD; Zhang YQ; Gong HY; Tang H; Zhang QL
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):340-5. PubMed ID: 19799081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Over-expression of Sox4 and β-catenin is associated with a less favorable prognosis of osteosarcoma.
    Bao ZQ; Zhang CC; Xiao YZ; Zhou JS; Tao YS; Chai DM
    J Huazhong Univ Sci Technolog Med Sci; 2016 Apr; 36(2):193-199. PubMed ID: 27072961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative proteomics analysis of human osteosarcomas and benign tumor of bone.
    Li Y; Liang Q; Wen YQ; Chen LL; Wang LT; Liu YL; Luo CQ; Liang HZ; Li MT; Li Z
    Cancer Genet Cytogenet; 2010 Apr; 198(2):97-106. PubMed ID: 20362224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of E-cadherin catenin complex and invasiveness of pituitary adenoma].
    Qu QY; Zhang QH; Wang XY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2006 Jun; 41(6):433-6. PubMed ID: 16927799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary investigation of Beta-hCG expression in patients with osteosarcoma.
    Masrouha KZ; Khattab R; Tawil A; Abdallah A; Saghieh S; Haidar R; Abboud M; Khoury NJ
    J Bone Joint Surg Br; 2012 Mar; 94(3):419-24. PubMed ID: 22371553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
    Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
    Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA
    Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.
    Harting MT; Blakely ML; Jaffe N; Cox CS; Hayes-Jordan A; Benjamin RS; Raymond AK; Andrassy RJ; Lally KP
    J Pediatr Surg; 2006 Jan; 41(1):194-9. PubMed ID: 16410132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is T-cadherin (CDH13, H-cadherin) expression related to lung metastasis of osteosarcoma?
    Takeuchi T; Misaki A; Sonobe H; Liang SB; Ohtsuki Y
    Histopathology; 2000 Aug; 37(2):193-4. PubMed ID: 10931247
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic significance of E-cadherin-catenin complex in epithelial ovarian cancer.
    Voutilainen KA; Anttila MA; Sillanpää SM; Ropponen KM; Saarikoski SV; Juhola MT; Kosma VM
    J Clin Pathol; 2006 May; 59(5):460-7. PubMed ID: 16461565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of E-cadherin and beta-catenin proteins in metastatic prostate cancer cells in bone.
    Saha B; Arase A; Imam SS; Tsao-Wei D; Naritoku WY; Groshen S; Jones LW; Imam SA
    Prostate; 2008 Jan; 68(1):78-84. PubMed ID: 18008331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.